Literature DB >> 20375233

Molecular detection and identification of zygomycetes species from paraffin-embedded tissues in a murine model of disseminated zygomycosis: a collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) evaluation.

Eric Dannaoui1, Patrick Schwarz, Michal Slany, Juergen Loeffler, Anne Tomine Jorde, Manuel Cuenca-Estrella, Philippe M Hauser, Raghdaa Shrief, Michel Huerre, Tomas Freiberger, Peter Gaustad, Juan-Luis Rodriguez-Tudela, Jacques Bille, David W Denning, Stéphane Bretagne, Olivier Lortholary.   

Abstract

The present study was performed to assess the interlaboratory reproducibility of the molecular detection and identification of species of Zygomycetes from formalin-fixed paraffin-embedded kidney and brain tissues obtained from experimentally infected mice. Animals were infected with one of five species (Rhizopus oryzae, Rhizopus microsporus, Lichtheimia corymbifera, Rhizomucor pusillus, and Mucor circinelloides). Samples with 1, 10, or 30 slide cuts of the tissues were prepared from each paraffin block, the sample identities were blinded for analysis, and the samples were mailed to each of seven laboratories for the assessment of sensitivity. A protocol describing the extraction method and the PCR amplification procedure was provided. The internal transcribed spacer 1 (ITS1) region was amplified by PCR with the fungal universal primers ITS1 and ITS2 and sequenced. As negative results were obtained for 93% of the tissue specimens infected by M. circinelloides, the data for this species were excluded from the analysis. Positive PCR results were obtained for 93% (52/56), 89% (50/56), and 27% (15/56) of the samples with 30, 10, and 1 slide cuts, respectively. There were minor differences, depending on the organ tissue, fungal species, and laboratory. Correct species identification was possible for 100% (30 cuts), 98% (10 cuts), and 93% (1 cut) of the cases. With the protocol used in the present study, the interlaboratory reproducibility of ITS sequencing for the identification of major Zygomycetes species from formalin-fixed paraffin-embedded tissues can reach 100%, when enough material is available.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20375233      PMCID: PMC2884487          DOI: 10.1128/JCM.02319-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

Review 1.  Tissue handling and specimen preparation in surgical pathology: issues concerning the recovery of nucleic acids from formalin-fixed, paraffin-embedded tissue.

Authors:  Stephen M Hewitt; Fraser A Lewis; Yanxiang Cao; Richard C Conrad; Maureen Cronin; Kathleen D Danenberg; Thomas J Goralski; John P Langmore; Rajiv G Raja; P Mickey Williams; John F Palma; Janet A Warrington
Journal:  Arch Pathol Lab Med       Date:  2008-12       Impact factor: 5.534

2.  Molecular diagnosis of Saksenaea vasiformis cutaneous infection after scorpion sting in an immunocompetent adolescent.

Authors:  Pauline Lechevalier; Dea Garcia Hermoso; Agnes Carol; Stephane Bonacorsi; Latifa Ferkdadji; Franck Fitoussi; Olivier Lortholary; Antoine Bourrillon; Albert Faye; Eric Dannaoui; Francois Angoulvant
Journal:  J Clin Microbiol       Date:  2008-07-16       Impact factor: 5.948

3.  Real-time PCR method for detection of zygomycetes.

Authors:  D Jane Hata; Seanne P Buckwalter; Bobbi S Pritt; Glenn D Roberts; Nancy L Wengenack
Journal:  J Clin Microbiol       Date:  2008-05-14       Impact factor: 5.948

4.  Evaluation of two nested PCR assays for detection of Histoplasma capsulatum DNA in human tissue.

Authors:  Ralf Bialek; Antje Feucht; Christian Aepinus; Gudrun Just-Nübling; Valerie J Robertson; Jürgen Knobloch; Rolf Hohle
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

Review 5.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

6.  Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers.

Authors:  Ana Alastruey-Izquierdo; Maria Victoria Castelli; Isabel Cuesta; Araceli Monzon; Manuel Cuenca-Estrella; Juan Luis Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2009-01-26       Impact factor: 5.191

7.  Molecular and phenotypic evaluation of Lichtheimia corymbifera (formerly Absidia corymbifera) complex isolates associated with human mucormycosis: rehabilitation of L. ramosa.

Authors:  Dea Garcia-Hermoso; Damien Hoinard; Jean-Charles Gantier; Frédéric Grenouillet; Françoise Dromer; Eric Dannaoui
Journal:  J Clin Microbiol       Date:  2009-09-16       Impact factor: 5.948

8.  Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis.

Authors:  Miki Kasai; Susan M Harrington; Andrea Francesconi; Vidmantas Petraitis; Ruta Petraitiene; Mara G Beveridge; Tena Knudsen; Jeffery Milanovich; Margaret P Cotton; Johanna Hughes; Robert L Schaufele; Tin Sein; John Bacher; Patrick R Murray; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2008-09-24       Impact factor: 5.948

9.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

10.  Taxonomic reliability of DNA sequences in public sequence databases: a fungal perspective.

Authors:  R Henrik Nilsson; Martin Ryberg; Erik Kristiansson; Kessy Abarenkov; Karl-Henrik Larsson; Urmas Kõljalg
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

View more
  31 in total

Review 1.  Molecular and nonmolecular diagnostic methods for invasive fungal infections.

Authors:  Marios Arvanitis; Theodora Anagnostou; Beth Burgwyn Fuchs; Angela M Caliendo; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  PCR-Based Approach Targeting Mucorales-Specific Gene Family for Diagnosis of Mucormycosis.

Authors:  Clara Baldin; Sameh S M Soliman; Heewon H Jeon; Sondus Alkhazraji; Teclegiorgis Gebremariam; Yiyou Gu; Vincent M Bruno; Oliver A Cornely; Helen L Leather; Michele W Sugrue; John R Wingard; David A Stevens; John E Edwards; Ashraf S Ibrahim
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

Review 3.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

4.  Future directions in mucormycosis research.

Authors:  Dimitrios P Kontoyiannis; Russell E Lewis; Oliver Lortholary; Oliver Lotholary; Brad Spellberg; Georgios Petrikkos; Emmanuel Roilides; Emmanuel Roillides; Ashraf Ibrahim; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

5.  Mucormycosis of the head and neck.

Authors:  Michael Dan
Journal:  Curr Infect Dis Rep       Date:  2011-04       Impact factor: 3.725

6.  Successful isavuconazole salvage therapy in a patient with invasive mucormycosis.

Authors:  J Ervens; M Ghannoum; B Graf; S Schwartz
Journal:  Infection       Date:  2013-11-12       Impact factor: 3.553

Review 7.  [PCR-based diagnosis of mucormycosis in tissue samples].

Authors:  R Bialek; U E Zelck
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

Review 8.  [Rational antibiotic treatment of mediastinitis].

Authors:  A Ambrosch
Journal:  Chirurg       Date:  2016-06       Impact factor: 0.955

9.  Identification of fungal pathogens in a patient with acute myelogenic leukemia using a pathogen detection array technology.

Authors:  Sagarika Banerjee; Kristen N Peck; Michael D Feldman; Mindy G Schuster; James C Alwine; Erle S Robertson
Journal:  Cancer Biol Ther       Date:  2016-04-02       Impact factor: 4.742

10.  Recent advances in the treatment of mucormycosis.

Authors:  Brad Spellberg; Ashraf S Ibrahim
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.